miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer
Authors:
Open Access
- 1 January 2017
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 38 (1) , 175-182
Abstract
Epidermal growth factor receptor (EGFR) plays an important role in various types of cancer. However, the therapeutic agents that target EGFR have not produced favorable results in gastric cancer. miRNAs are known to regulate gene expression at the post-transcriptional level. We wondered if miRNAs could be potential therapeutic agents for the targeted therapy against EGFR. In this study, we found an increase in the copies of EGFR mRNA and the upregulated expression of the EGFR protein in gastric cancer tissues compared with normal gastric tissues. Both bioinformatic analysis and luciferase reporter assay revealed that miR-455 could directly bind with the 3'-untranslated region (3'UTR) of EGFR mRNA. Subsequently, in vitro studies were conducted to identify the effects of miR-455 on cell proliferation and migration and further confirm the cancer-promoting role of EGFR in gastric cancer. The results revealed that miR-455 negatively regulated EGFR expression at the post-transcriptional level, thus suppressing cell growth and migration. To conclude, our results offer a potential targeted therapeutic method against EGFR in gastric cancer mediated by miR-455.Keywords
This publication has 31 references indexed in Scilit:
- The global decrease in cancer mortality: trends and disparitiesAnnals of Oncology, 2016
- MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancerCancer Gene Therapy, 2015
- Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysisLung Cancer, 2015
- Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancerBritish Journal of Cancer, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinomaGastric Cancer, 2014
- The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapyRadiation Oncology, 2012
- Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs): Simple drugs with a complex mechanism of action?Journal of Cellular Physiology, 2002
- The epidermal growth factor receptor as a target for cancer therapy.Endocrine-Related Cancer, 2001
- Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2001